MEKICS CO., Ltd cancelled the acquisition of remaining 33.5% stake in MEK Healthcare Co., Ltd.
February 11, 2021
Share
MEKICS CO., Ltd (KOSDAQ:A058110) agreed to acquire remaining 33.5% stake in MEK Healthcare Co., Ltd. for approximately ¥420 million on February 12, 2020. MEKICS CO., Ltd entered into stock exchange contract on February 14, 2020. As per terms, MEKICS CO., Ltd will issue 0.29114 new stock of MEKICS for per share of MEK Healthcare. Post completion, MEKICS CO., Ltd will become a complete parent company of MEK Healthcare Co., Ltd. For the year ended December 31, 2019, MEK Healthcare Co., Ltd. reported total assets of ¥3.1 billion and net assets of ¥560.8 million. The transaction is approved by the shareholders of both parties on February 27, 2020. The board of Stock Exchange approved the transaction on March 16, 2020. The transaction is expected to close on April 18, 2020. The scheduled delivery date of new certificate is May 7, 2020.
MEKICS CO., Ltd (KOSDAQ:A058110) cancelled the acquisition of remaining 33.5% stake in MEK Healthcare Co., Ltd. on February 12, 2021.
MEKICS CO., Ltd is a Korea-based company principally engaged in manufacturing medical equipment. The Companyâs products mainly consist of artificial respirators used for critical patient and newborns, portable artificial respirators used for emergency, high oxygen artificial respirators , continuous positive pressure respirators ,patient monitors used for monitoring patient vital sign , measuring appliance used for measuring oxygen saturation.